Calls Purchased on Medicis Pharma (MRX)
June 21, 2010 2:29 PM
Shares of Medicis Pharmaceuticals Corp. (NYSE: MRX) are lower on the session by 0.39%, currently trading at $23.11. The stock has been drifting lower over the past six months and is currently in a technical downtrend.
Options traders are betting that shares could move higher, though and are buying calls. The August $22.50 call was purchased 1,000 times, on the offer, for $1.90; there was no open interest on the strike.
Call volume is now running at 3.77x the daily average.
Medicis Pharmaceutical Corporation is a specialty pharmaceutical company that focuses primarily on helping patients attain a healthy and youthful appearance and self-image through the development and marketing in the United States of products for the treatment of dermatological and aesthetic conditions.
